AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest

Zhou, W; Lou, WY; Chen, JR; Ding, BS; Chen, BJ; Xie, HY; Zhou, L; Zheng, SS; Jiang, DH

Zheng, SS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Surg, Hangzhou, Peoples R China.; Zheng, SS; Jiang, DH (corresponding author), NHFPC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China.; Zheng, SS; Jiang, DH (corresponding author), Key Lab Diag & Treatment Organ Transplantat, Hangzhou, Peoples R China.; Jiang, DH (corresponding author), Key Lab Organ Transplantat, Hangzhou, Peoples R China.

ONCOTARGETS AND THERAPY, 2021; 14 (): 1049

Abstract

Purpose: The frequency in resistance to sorafenib accounts for the grim prognosis of advanced hepatocellular carcinoma (HCC). In the present study, we......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索